# Longboard Pharmaceuticals, Inc. — Form D

Longboard Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-18. The offering totals $56.0M, of which $56.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-11-18
- Form: D
- Accession: 0001832168-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $56.0M
- Amount sold: $56.0M
- Investors: 17
- Date of first sale: 2020-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380882

## Issuer

- Name: Longboard Pharmaceuticals, Inc.
- CIK: 0001832168
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6154 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: 619-592-9775

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Vincent R Aurentz | Director | San Diego, CA |
| Chandra R Leo | Director | San Diego, CA |
| Kevin R Lind | Director | San Diego, CA |
| Laurie R Stelzer | Director | San Diego, CA |
| Kevin R Lind | Executive Officer | San Diego, CA |

## More

- [CIK 1832168 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1832168&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001832168-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.